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Abstract
Background: Canine vector-borne diseases (CVBDs) are caused by a wide range of pathogens transmitted to dogs
by arthropods including ticks and insects. Many CVBD-agents are of zoonotic concern, with dogs potentially
serving as reservoirs and sentinels for human infections. The present study aimed at assessing the seroprevalence
of infection with or exposure to Dirofilaria immitis, Ehrlichia canis, Borrelia burgdorferi sensu lato, Anaplasma spp.
and Leishmania infantum in dogs in Portugal.
Methods: Based on 120 veterinary medical centres from all the regions of mainland and insular Portugal, 557
apparently healthy and 628 CVBD-suspect dogs were sampled. Serum, plasma or whole blood was tested for
qualitative detection of D. immitis antigen and antibodies to E. canis, B. burgdorferi s. l., Anaplasma spp. and L.
infantum with two commercial in-clinic enzyme-linked immunosorbent assay kits. Odds ratios (OR) were calculated
by logistic regression analysis to identify independent risk factors of exposure to the vector-borne agents.
Results: Total positivity levels to D. immitis, E. canis, B. burgdorferi, Anaplasma spp., L. infantum, one or more agents
and mixed agents were 3.6%, 4.1%, 0.2%, 4.5%, 4.3%, 14.0% and 2.0% in the healthy group, and 8.9%, 16.4%, 0.5%,
9.2%, 25.2%, 46.3% and 11.6% in the clinically suspect group, respectively. Non-use of ectoparasiticides was a risk
factor for positivity to one or more agents both in the apparently healthy (OR = 2.1) and CVBD-suspect (OR = 1.5)
dogs. Seropositivity to L. infantum (OR = 7.6), E. canis (OR = 4.1) and D. immitis (OR = 2.4) were identified as risk
factors for the presence of clinical signs compatible with CVBDs. Positivity to mixed agents was not found to be a
risk factor for disease.
Conclusions: Dogs in Portugal are at risk of becoming infected with vector-borne pathogens, some of which are
of zoonotic concern. CVBDs should be considered by practitioners and prophylactic measures must be put in place
to protect dogs and limit the risk of transmission of vector-borne agents to humans. This study is expected to give
veterinary and public health authorities an increased awareness about CVBDs in Portugal and to serve as a
reference for future investigations and control actions.
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Canine vector-borne diseases (CVBDs) are an emerging
problem worldwide due to their frequency and morbid-
ity and, in most cases, also to their zoonotic relevance,
with dogs potentially serving as sentinels for human
i n f e c t i o n[ 1 ] .C V B D sa r ec a u s e db yad i v e r s er a n g eo f
pathogens, mainly bacteria and parasites, which are
transmitted to dogs by different arthropod vectors, par-
ticularly ticks and insects [2].
Nematode Dirofilaria immitis, bacteria Ehrlichia canis,
Borrelia burgdorferi sensu lato, Anaplasma phagocyto-
philum and Anaplasma platys, and protozoan Leishma-
nia infantum are among of the major vector-borne
agents that can infect dogs [3].
D. immitis is transmitted by mosquitoes primarily
from genera Culex, Aedes and Anopheles, and causes
dirofilariosis or heartworm disease, a potentially fatal
condition in dogs [4]. Canine dirofilariosis is associated
with a dry chronic cough, exercise intolerance, dys-
pnoea, weakness, weight loss, epistaxis, cyanosis and
congestive heart failure [5]. Dogs are the natural hosts,
but infection may also occur in other canids and cats,
and there is also a risk of zoonotic transmission [6].
Human heartworm infections are relatively uncommon;
nevertheless, D. immitis can cause pulmonary dirofilar-
iosis in people with the occurrence of granulomas in the
lungs [7,8].
E. canis, a causative agent of acute or chronic canine
monocytic ehrlichiosis, is transmitted by the brown dog
tick, Rhipicephalus sanguineus [9]. Dogs infected with E.
canis present a spectrum of disease that ranges from
subclinical infection to fatal illness [10]. Clinical signs
often include lethargy, anorexia, weight loss, hyperther-
mia, epistaxis and other haemorrhagic disorders, pale
mucous membranes and lymph node enlargement [11].
E. canis has a zoonotic potential as human infections
have been reported from Venezuela [12].
B. burgdorferi s.l. spirochetes infect mammals, includ-
ing dogs and human beings, and cause the so-called
Lyme disease [13]. In Europe, Ixodes ricinus ticks are
important vectors of B. burgdorferi s.l. [9]. Most people
exposed to B. burgdorferi show mild non-specific symp-
tomatology, but Lyme borreliosis can be a chronic debil-
itating disease in humans, with arthritis, skin changes
and neurological or cardiac dysfunction [14]. In con-
trast, relatively few infected dogs demonstrate clinical
signs. However, canine borreliosis has been associated
with lethargy, hyperthermia, anorexia, joint inflamma-
tion, lameness, lymphadenopathy and glomerulonephri-
tis [15].
A. phagocytophilum, the agent of granulocytic anaplas-
mosis, is vectored in Europe by I. ricinus and can infect
a wide range of domestic and wild vertebrate hosts,
including rodents, horses, dogs and humans [16].
Infection in dogs may be subclinical or result in a mild
to severe acute illness, with lethargy, anorexia,
hyperthermia, lameness and, occasionally, polydipsia,
vomiting, diarrhoea and even neurologic signs [17]. In
human beings A. phagocytophilum induces a febrile syn-
drome associated with myalgia and headache, and is
considered an emerging pathogen [18].
A. platys is a bacterium primarily of dogs that infects
platelets and may cause canine infectious cyclic throm-
bocytopenia [16]. Clinical signs include abnormalities
such as lymphadenomegaly and pale mucous mem-
branes, but canine infections with A. platys are mostly
subclinical [19]. Although its virulence is generally low,
A. platys might play a role in co-infection with other
vector-borne agents [9]. The presumed vector of A.
platys is R. sanguineus.
Dogs are the main reservoir of L. infantum,w h i c hi s
transmitted among canines and to humans by phleboto-
mine sand fly insects, Phlebotomus spp. in Europe [20].
Canine leishmaniosis is a systemic chronic condition
whose clinical manifestations usually include lymphade-
nopathy, dermatitis, alopecia, cutaneous ulceration, ony-
chogryphosis, lameness, weight loss, cachexia, ocular
lesions, epistaxis, anaemia and renal failure [21]. A large
majority of the infected dogs do not develop clinical
signs but they may still be capable of transmitting the
parasite to the vectors [22]. In people, visceral leishma-
niosis is the most severe clinical syndrome resulting
from infections with L. infantum, and in Europe it is
observed mainly in children and immunocompromised
adults [23]. Leishmaniosis due to L. infantum is a major
zoonosis potentially fatal to dogs and humans, and
infected dogs represent an important veterinary medical
and public health problem [24].
Dogs can be sequentially or simultaneously infected
with more than one vector-borne agent by being
exposed to arthropods infected with a single pathogen
species or to vector(s) concurrently infected with differ-
ent organisms [2,25]. Some arthropod species, particu-
larly ticks, act as vectors of more than one agent and
co-infection of individual arthropods can occur [9].
Awareness of canine co-infections is an important clini-
cal and diagnostic issue as they might induce more
severe pathological effects than infections with either
agent alone [26].
Diagnosis and screening are essential for the control
of CVBDs, both at the individual and population levels,
with detection methods including cytological examina-
tion of blood smears or other tissues, serology (for anti-
bodies or antigens) and the polymerase chain reaction
(PCR). Evidence of infection with or exposure to the
causative agents of dirofilariosis, ehrlichiosis, borreliosis,
anaplasmosis and leishmaniosis can be assessed via
rapid in-clinic serological testing [27]. Results of either
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tion with data on the geographical origin, history of vec-
tor exposure and clinical status of dogs, along with
other confirmatory tests [28].
Environmental changes, especially global warming,
have an impact on the arthropods geographical distribu-
tion, abundance and vectorial capacity [29]. Together
with human and animal population dynamics, including
the increased mobility of dogs, climatic changes may
affect the occurrence and spread of CVBDs [2]. Updated
information on the epidemiology of infection and dis-
ease is required to map regional risk, identify new areas
of endemicity and forecast CVBD scenarios [30].
D. immitis, E. canis, B. burgdorferi s. l., A. phagocyto-
philum, A. platys and L. infantum have been detected in
Portugal in dogs and/or arthropods [31,32]. Neverthe-
less, except for the latter [33], there is no comprehensive
data available on the regional distribution and preva-
lence of these vector-borne agents at the countrywide
level. The present study aimed at assessing the seropre-
valence of infection with or exposure to D. immitis, E.
canis, B. burgdorferi s. l., Anaplasma spp. and L. infan-
tum in healthy and CVBD-suspect dogs in Portugal.
Methods
Veterinary medical centres and dogs
This study was based on a convenience sample of 120
veterinary medical centres from all the Portuguese
NUTS (Nomenclature of Units for Territorial Statistics)
regions that represented ~15% of the veterinary centres
in the country. Point-of-care tests were delivered to 28
centres in the North, 24 in the Centre, 20 in Alentejo,
27 in Lisbon, 19 in the Algarve, one in the Azores and
another one in Madeira (Figure 1). Based on a physical
examination, local veterinarians were asked to randomly
seek for 5 apparently healthy dogs and 5 dogs clinically
suspect of a vector-borne disease, including dirofilario-
sis, ehrlichiosis, borreliosis, anaplasmosis or
leishmaniosis.
Suspect or symptomatic dogs had at least one clinical
sign of disease, including alopecia, anorexia, cutaneous
ulceration, cyanosis, dermatitis, diarrhoea, dry chronic
cough, dyspnoea, epistaxis, exercise intolerance, haemor-
rhagic disorders, hyperthermia, joint inflammation,
lameness, lethargy, lymph node enlargement, neurologic
signs, ocular lesions, onychogryphosis, pale mucous
membranes, polydipsia, vomiting, weakness and weight
loss. Healthy or asymptomatic dogs had no signs or his-
torical abnormalities.
From October 2010 to April 2011, 557 apparently
healthy dogs and 628 CVBD-suspect dogs were sampled
with oral consent from owners. Information was
recorded on the animals’ g e n d e r ,a g e ,l i f e s t y l e( i n d o o r s
versus outdoors or mixed), detectable tick infestation,
use of ectoparasiticides (acaricides and/or insecticides)
and NUTS where they lived. Travel histories were not
available.
In the healthy group there were 269 females and 288
males. Median age was 5.0 years (interquartile range
[IQR]: 2.0-8.0); age was not recorded for 2 dogs. There
were 61 animals aged 12 months or less and 494 older
than 12 months. Sixty-five dogs had an indoor lifestyle
a n d5 6 2h a da no u t d o o ro rm i x e do n e .T h e r ew e r en o
detectable ticks in 535 dogs, while 22 had ticks. Ectopar-
asiticides were used on 371 but not on 168 dogs; no
information was available from 18 animals. The num-
bers of apparently healthy dogs sampled by NUTS are
shown in Table 1.
Among the CVBD-suspect dogs there were 262
females and 366 males. Median age was 6.0 years (IQR:
3.0-9.0); age was not recorded for 2 animals. Forty-five
dogs had 12 months or less and 581 were older than 12
months. Seventy dogs had an indoor lifestyle and 487
had an outdoor or mixed lifestyle; no information was
available from one animal. There were no detectable
ticks in 577 dogs, while 51 had ticks. Ectoparasiticides
were used on 302 but not on 270 dogs; no information
was available from 56 animals. The numbers of clinically
suspect dogs sampled by NUTS are shown in Table 2.
Testing for serum antigen and antibodies
Serum, plasma or whole blood samples from dogs were
screened for simultaneous qualitative detection of circu-
lating D. immitis antigen and antibodies, both immuno-
globulin G and M, to E. canis, B. burgdorferi sensu lato
and Anaplasma spp. with SNAP
® 4Dx
® test. The same
Figure 1 Positivity to one or more agents in apparently
healthy (A) and CVBD-suspect dogs (B) by region. * Significant
difference to the national average. See Tables 1 and 2 for CI for the
percentages.
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to L. infantum with SNAP
® Leishmania. These two
rapid tests are commercially available in-clinic enzyme-
linked immunosorbent assay (ELISA) kit devices from
IDEXX Laboratories (Westbrook, Maine, USA) and
were operated according to the manufacturer’si n s t r u c -
tions listed in the product package insert.
The SNAP
® 4Dx
® D. immitis analyte is derived from
polyclonal antibodies specific to a carbohydrate antigen
of the adult female heartworms [34]. The commercially
available in-clinic ELISA detects antibodies against pep-
tides from p30 and p30-1 outer membrane immunodo-
minant proteins of E. canis [35]. The B. burgdorferi s. l.
analyte detects antibodies specific to the C6 synthetic
peptide derived from the IR6 region within the Borrelia
membrane protein VlsE [36]. This peptide does not
react with antibodies elicited following B. burgdorferi
vaccination [37]. The Anaplasma spp. analyte detects
antibodies reacting to a synthetic peptide derived from
the immunodominant major outer surface protein (p44/
MSP2) of A. phagocytophilum [38]. Preliminary studies
indicate that the A. phagocytophilum analyte in SNAP
®
4Dx
® cross-reacts with samples from A. platys infected
dogs (SNAP
® 4Dx
® kit insert, unpublished observations)
[27]. The antigen used in SNAP
® Leishmania is derived
from L. infantum promastigotes prepared by sonic dis-
ruption, filtration and diethylaminoethyl column purifi-
cation [39].
Reported sensitivities/specificities of the SNAP
® 4Dx
®
test are 99.2%/100% for D. immitis, 96.2%/100% for E.
canis, 98.8%/100% for B. burgdorferi s. l. and 99.1%/
100% for A. phagocytophilum [34]. Sensitivity and speci-
ficity of SNAP
® Leishmania were 91.1/93.4% and 98.3/
99.2%, respectively compared with an immunofluores-
cence antibody test (IFAT) or Western blot [39].
Data analysis
Exact binomial test was used to calculate confidence
intervals (CI) for the proportions, with a 95% confidence
level. Chi-square and Fisher’s exact tests compared pro-
portions of positivity (no. of dogs found positive divided
by the no. of dogs tested) related to categorical depen-
dent variables. Analyses were done with StatLib or SPSS
11.5 software for Windows. A probability (p)v a l u e<
0.05 was regarded as statistically significant. Binomial
variables showing a significant difference between
Table 1 Prevalence of positivity to vector-borne agents in 557 apparently healthy dogs by Portuguese NUTS region
Region
(n)
D. immitis
(95% CI)
E. canis
(95% CI)
B. burgdorferi s.l.
(95% CI)
Anaplasma spp.
(95% CI)
L. infantum
(95% CI)
One or more agents
(95% CI)
Mixed agents
(95% CI)
North (137) 2.9% (0.8-7.3) 0.7% (0.0-4.0) 0.0% (0.0-2.7) 2.2% (0.5-6.3) 3.6% (1.2-8.3) 8.8% (4.6-14.8) 0.7% (0.0-4.0)
Centre (113) 0.9% (0.0-4.8) 0.9% (0.0-4.8) 0.0% (0.0-3.2) 2.7% (0.6-7.6) 0.9% (0.0-4.8) 5.3%* (2.0-11.2) 0.0% (0.0-3.2)
Alentejo (85) 4.7% (1.3-11.6) 2.4% (0.3-8.2) 1.2% (0.0-6.4) 3.5% (0.7-10.0) 5.9% (1.9-13.2) 15.3% (8.4-24.7) 1.2% (0.0-6.4)
Lisbon (126) 2.4% (0.5-6.8) 6.3% (2.8-12.1) 0.0% (0.0-29) 6.3% (2.8-12.1) 7.9% (3.9-14.1) 17.5% (11.3-25.2) 4.0% (1.3-9.0)
Algarve (79) 5.1% (1.4-12.5) 13.9%* (7.2-23.5) 0.0% (0.0-4.6) 10.1%* (4.5-19.0) 3.8% (0.8-10.7) 26.6%* (17.3-37.7) 5.1% (1.4-12.5)
Azores (7) 0.0% (0.0-41.0) 0.0% (0.0-41.0) 0.0% (0.0-41.0) 0.0% (0.0-41.0) 0.0% (0.0-41.0) 0.0% (0.0-41.0) 0.0% (0.0-41.0)
Madeira (10) 40.0%* (12.1-73.8) 0.0% (0.0-30.8) 0.0% (0.0-30.8) 0.0% (0.0-30.8) 0.0% (0.0-30.8) 40.0%* (12.1-73.8) 0.0% (0.0-30.8)
Total (557) 3.6% (2.2-5.5) 4.1% (2.6-6.1) 0.2% (0.0-1.0) 4.5% (2.9-6.5) 4.3% (2.8-6.3) 14.0% (11.2-17.2) 2.0% (1.0-3.5)
* Statistically significant difference (p < 0.05) to the corresponding national average value of prevalence.
Table 2 Prevalence of positivity to vector-borne agents in 628 CVBD-suspect dogs by Portuguese NUTS region
Region
(n)
D. immitis
(95% CI)
E. canis
(95% CI)
B. burgdorferi
s.l.
(95% CI)
Anaplasma spp.
(95% CI)
L. infantum
(95% CI)
One or more
agents
(95% CI)
Mixed agents
(95% CI)
North (145) 3.4%* (1.1-7.9) 7.6%* (3.8-13.2) 0.7% (0.0-3.8) 5.5% (2.4-10.6) 18.6% (12.6-
25.9)
30.3%* (23.0-38.5) 4.1%* (1.5-8.8)
Centre (122) 7.4% (3.4-13.5) 9.0%* (4.6-15.6) 0.8% (0.0-4.5) 3.3%* (0.9-8.2) 25.4% (18.0-
34.1)
37.7% (29.1-46.9) 7.4% (3.4-13.5)
Alentejo
(114)
14.0% (8.2-21.8) 25.4%* (17.7-
34.4)
0.0% (0.0-3.2) 9.6% (4.9-16.6) 27.2% (19.3-
36.3)
61.4%* (51.8-70.4) 13.2% (7.6-20.8)
Lisbon (139) 5.8% (2.5-11.0) 19.4% (13.2-27.0) 0.7% (0.0-3.9) 11.5% (6.7-18.0) 30.2% (22.7-
38.6)
48.9% (40.3-57.5) 15.8% (10.2-23.0)
Algarve (105) 17.1%* (10.5-
25.7)
23.8% (16.0-31.1) 0.0% (0.0-3.4) 17.1%* (10.5-
25.7)
25.7% (17.7-
35.2)
59.0%* (49.0-68.5) 20.0%* (12.8-
28.9)
Azores (3) 0.0% (0.0-70.8) 0.0% (0.0-70.8) 0.0% (0.0-70.8) 33.3% (0.8-90.6) 0.0% (0.0-70.8) 33.3% (0.8-90.6) 0.0% (0.0-70.8)
Total (628) 8.9% (6.8-11.4) 16.4% (13.6-19.5) 0.5% (0.1-1.4) 9.2% (7.1-11.8) 25.2% (21.8-
28.7)
46.3% (42.4-50.3) 11.6% (9.2-14.4)
* Statistically significant difference (p < 0.05) to the corresponding national average value of prevalence.
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logistic regression analysis to identify independent risk
factors of exposure to the vector-borne agents, calculat-
ing odds ratios (OR) and their 95% CI [40].
Results
Total and regional positivity of healthy dogs to the sev-
eral vector-borne agents and to the parameters of one
or more agents (≥ 1 agent) and mixed agents (≥ 2
agents) are displayed in Table 1. A map of positivity to
o n eo rm o r ea g e n t sb yN U T Si sf u r t h e rp r e s e n t e di n
Figure 1 (A). Risk factors identified in apparently healthy
dogs are shown in Table 3.
Table 2 displays data on the total and regional positiv-
ity of clinically suspect dogs to the vector-borne agents
and to the other two parameters. Figure 1 (B) shows a
map with positivity to one or more agents by NUTS
region. Table 4 presents risk factors identified in CVBD-
suspect dogs.
In decreasing order, seropositivity to L. infantum (OR
= 7.6, 95% CI: 4.8-11.9; p < 0.001), E. canis (OR = 4.1,
95% CI: 2.5-6.7; p <0 . 0 0 1 )a n dD. immitis (OR = 2.4,
95% CI: 1.4-4.2; p = 0.002) were risk factors for the pre-
sence of clinical signs compatible with a CVBD. In uni-
variate analysis, positivity to mixed agents was not
found to be a risk factor for clinical signs; positivity to
one or more agents was not assessed by logistic
regression.
Table 5 describes positivity to single and mixed vec-
tor-borne agents among the apparently healthy and the
clinically suspect dogs. No dog was positive for all
agents; 479 healthy (86.0%) and 337 suspect dogs
(53.7%) were negative for all five tests.
Discussion
This is the most comprehensive study carried out in
Portugal on the prevalence of infection with or exposure
to CVBD-agents regarding the diversity of pathogens
and/or the geographical areas under assessment.
Table 3 Risk factors for E. canis, Anaplasma spp. and one
or more agents in apparently healthy dogs
Dependent variable/
/risk factor
p value OR 95% CI
Positivity to E. canis
Positivity to Anaplasma spp. < 0.001 20.8 7.9-55.1
Positivity to Anaplasma spp.
Detectable ticks = 0.185 2.7 0.6-11.4
Non-use of ectoparasiticides = 0.079 2.3 0.9-5.7
Positivity to E. canis < 0.001 20.7 7.4-58.1
Positivity to one or more agents
Age > 12 months = 0.040 3.5 1.1-11.5
Non-use of ectoparasiticides = 0.004 2.1 1.3-3.4
Table 4 Risk factors for positivity to vector-borne agents
and combined parameters in CVBD-suspect dogs
Dependent variable/
/risk factor
p value OR 95% CI
Positivity to D. immitis
Age > 12 months = 0.997 1.5
8 0.0-ND
Outdoor or mixed lifestyle = 0.073 6.2 0.8-46.1
Positivity to E. canis = 0.036 2.0 1.0-3.7
Positivity to E. canis
Age > 12 months = 0.088 3.5 0.8-15.1
Positivity to D. immitis = 0.085 1.8 0.9-3.5
Positivity to Anaplasma spp. < 0.001 6.1 3.5-10.9
Positivity to Anaplasma spp.
Non-use of ectoparasiticides = 0.011 2.2 1.2-4.2
Positivity to E. canis < 0.001 7.4 4.0-13.5
Positivity to L. infantum
Age > 12 months = 0.030 2.7 1.1-7.4
Positivity to one or more agents
Age > 12 months < 0.001 4.2 1.9-9.3
Outdoor or mixed lifestyle = 0.004 2.5 1.3-4.7
Non-use of ectoparasiticides = 0.022 1.5 1.1-2.1
Positivity to mixed agents
Age > 12 months < 0.001 4.4 2.0-9.6
Outdoor or mixed lifestyle = 0.003 2.4 1.4-4.3
ND: not defined.
Table 5 Positivity to single and mixed vector-borne
agents among 557 apparently healthy and 628 CVBD-
suspect dogs
Agents Healthy
(n)
% Suspect
(n)
%
Single agents 67 12.0
a 218 34.7
a
Di 17 3.1 30 4.8
Ec 14 2.5
b 47 7.5
b
Bb 1 0.2 1 0.2
Ap 16 2.9 20 3.2
Li 19 3.4
c 120 19.1
c
Mixed agents 11 2.0
d 73 11.6
d
Di + Ec 0 0.0
e 6 0.9
e
Di + Ap 0 0.0 2 0.3
Di + Li 2 0.4 7 1.1
Ec + Bb 0 0.0 1 0.2
Ec + Ap 5 0.9
f 20 3.1
f
Ec + Li 0 0.0
g 17 2.7
g
Bb + Li 0 0.0 1 0.2
Ap + Li 0 0.0
h 6 0.9
h
Di + Ec + Ap 1 0.2 6 0.9
Di + Ec + Li 0 0.0 3 0.5
Di + Ap + Li 0 0.0 1 0.2
Ec + Ap + Li 3 0.5 2 0.3
Di + Ec + Ap + Li 0 0.0 1 0.2
One or more agents 78 14.0
i 291 46.3
i
Di: D. immitis; Ec: E. canis;B b :B. burgdorferi s. l.; Ap: Anaplasma spp.; Li: L.
infantum;
a-i Statistically significant difference (p < 0.05).
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antigen-positive samples was obtained from Madeira
(40%), with a significant difference to the national aver-
age for heartworm (3.6%; Table 1). The prevalence of
D. immitis was not assessed in CVBD-suspect dogs
from Madeira, but it is predictable that it would surpass
t h ep r e v a l e n c ei nt h ea p p a r e n t l yh e a l t h yo n e s .I nf a c t ,
non-detection of exposure to any other vector-borne
agent under assessment strongly suggests that dirofilar-
iosis is the major endemic CVBD in Madeira. In another
investigation, Araujo [7] reported a prevalence of canine
infection with heartworm microfilariae of 30% in
Madeira, 16.5% in Alentejo and 12% in the Algarve. Pre-
valence may be underestimated if testing is only done
for microfilariae and not also for heartworm antigen to
reveal occult infection, i.e. adult nematode infection
without circulating microfilariae [28,41]. Furthermore,
canine filariae Acanthocheilonema dracunculoides and
Acanthocheilonema reconditum exist in Portugal and
their microfilariae need to be distinguished from those
of D. immitis by morphological criteria, staining for acid
phosphatase activity or PCR [31,41]. Cross-reactivity
with A. dracunculoides or A. reconditum has not been
reported for the heartworm antigen test kits. The rapid
ELISA test used in the present study has shown to be
highly specific, but sensitivity may decline in dogs with
worm burdens of two heartworm females or less [41,42].
Under these circumstances, seropositivity of D. immitis
antigen may underestimate the true prevalence of infec-
tion with the heartworm.
T h es e r o p r e v a l e n c eo fa n t i b o d i e st oE. canis was sig-
nificantly higher in the apparently healthy dogs from the
A l g a r v ea n di nt h eC V B D - s u s p e c to n e sf r o mA l e n t e j o
(Tables 1 and 2). On the other hand, positivity to E.
canis was significantly lower in the North and the Cen-
tre, although it reached regional levels of 7.6% and 9.0%,
respectively (Table 2). Molecular identification of E.
canis by PCR and DNA sequencing has recently been
reported in northeastern Portugal [43,44] and in the
Algarve [45]. The vector of E. canis, R. sanguineus,i s
the most prevalent tick species of dogs in Portugal and
has been found throughout all the regions of the main-
land [46]. Seropositivity to E. canis w a si d e n t i f i e da sa
risk factor for D. immitis in the suspect group, probably
due to a coincidental higher exposure of E. canis-posi-
tive dogs to the heartworm (Table 4).
Seroprevalence to B. burgdorferi s. l. was the lowest
countrywide. Evidence of exposure to the agent of Lyme
d i s e a s ew a sf o u n di no n l yo n eh e a l t h yd o gf r o mA l e n -
tejo (Table 1) and in three suspect dogs from the North,
the Centre and Lisbon (Table 2). Antibodies to the spir-
ochete were not detected in dogs either apparently
h e a l t h yo rC V B D - s u s p e c tf r o mt h eA z o r e s ,t h eA l g a r v e
and Madeira. Nevertheless, DNA of B. burgdorferi s. l.
(genospecies B. burgdorferi sensu stricto, Borrelia garinii
and Borrelia afzelii) has been detected in I. ricinus from
Madeira [47]. In addition, B. burgdorferi s. l. genospecies
Borrelia lusitaniae was found in I. ricinus ticks from a
sylvatic habitat in the southern part of the Lisbon region
[48]. Other serological studies with IFATs in dogs
revealed higher positivity levels in the north-eastern part
of Portugal (12.7%) [43] and the Algarve (2.3%) [49].
Differences to the present study may be related with the
subpopulations surveyed, which in the study conducted
in the Northeast, exclusively comprised of rural and
hunting dogs [43].
The seroprevalence of antibodies to Anaplasma spp. was
significantly higher in the Algarve, for both healthy and
suspect dogs, and lower in the Centre, but only for the lat-
ter (Tables 1 and 2). Serology has indicated the presence
of A. phagocytophilum in wild rodents, horses, dogs and
human beings in Portugal, although molecular evidence
has only been achieved in one seropositive horse [50].
Additionally, two species of Ixodes were found to harbour
A. phagocytophilum DNA: I. ricinus from Madeira and I.
ventalloi from the southern part of Lisbon region [50]. On
the other side, A. platys infections have been identified by
PCR and DNA sequencing in dogs from the North [44]
and in A. phagocytophilum-seropositive dogs from
the Algarve [51]. Serological cross-reactivity between A.
phagocytophilum and A. platys is likely to occur, but
sensitivity of the in-clinic ELISA test for the detection of
antibodies to A. platys still needs to be determined [34].
For specific identification of the canine Anaplasma patho-
gens it is useful to complement serological screening with
molecular-based detection methods [38].
L. infantum-positive dogs were distributed throughout
all the regions in the mainland, with prevalence being
significantly higher in the CVBD-suspect animals. Anti-
bodies to the protozoan were not detected in dogs from
the Azores or from Madeira. The 4.3% prevalence in the
apparently healthy group (Table 1) is statistically similar
to the 5.8% seroprevalence from another canine survey,
with the DAT (direct agglutination test), in mainland
Portugal [33]. In the present study, the percentage of
Leishmania-positive clinically suspect dogs was higher
(p < 0.001) than that of any other agent under assess-
ment (Table 2). Seropositivity to L. infantum as a single
agent was also significantly different between apparently
healthy and clinically suspect dogs (Table 5). These find-
ings suggest that L. infantum, either as a single or mixed
pathogen, was the main cause of illness in dogs, among
the vector-borne agents assessed. Nevertheless, they
could also indicate that practitioners better recognise
the clinical signs of leishmaniosis than those of other
CVBDs. In fact, canine leishmaniosis is a common rea-
son why dogs are brought into veterinary centres in Por-
tugal [52].
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phically, evidence of current or previous infection with
at least one vector-borne agent was found in dogs from
all the regions (Tables 1 and 2; Figure 1). Overall, a
southerly trend of positivity to D. immitis, E. canis, Ana-
plasma spp., one or more agents and mixed agents was
observed both in the apparently healthy and CVBD-sus-
pect dogs. Differences in the regional seroprevalence
levels of vector-borne agents are largely determined by
the geographical distribution and local density of their
arthropod vectors [53]. In the southern regions of the
country (Alentejo, Lisbon, the Algarve and Madeira) cli-
matic conditions might be more favourable to the prolif-
eration and abundance of vectors. Nevertheless, there
were still considerable levels of infection with or expo-
sure to those agents and their combinations in the
North and Centre. Travel histories were not available
and the chance of dogs found positive in one region
that were infected with or exposed to vector-borne
pathogens in another region cannot be excluded.
Age above 12 months, an outdoor or mixed lifestyle
and the non-use of ectoparasiticides were identified as
risk factors for several dependent variables (Tables 3
and 4). Higher positivity levels for those defined vari-
ables are most likely related to an increased cumulative
exposure of dogs to arthropod vectors and the agents
they transmit. Both apparently healthy and CVBD-sus-
pect dogs which received ectoparasiticides, i.e. commer-
cially available acaricides and/or insecticides, had a
significantly lower risk (OR) for positivity to one or
more agents. In fact, infections with E. canis, B. burgdor-
feri, Anaplasma spp. and L. infantum can be prevented
by the direct application on dogs of compounds with
acaricidal/insecticidal and anti-feeding properties
[54,55]. Besides preventing CVBDs, large spectrum ecto-
parasiticides also protect dogs from blood loss, local
skin disorders and systemic toxicoses potentially caused
by arthropod vectors [56]. Prevention of heartworm
infection is widely attainable by chemoprophylaxis with
macrocyclic lactones [38]. Preventative measures further
comprise vaccines against a few CVBDs, including Lyme
borreliosis and leishmaniosis [13,20].
Although positive serological results may suggest prior
exposure and not necessarily disease, they can alert
veterinarians to take into consideration further clinical
and diagnostic evaluation of individual dogs [57]. A sig-
nificantly higher seropositivity to E. canis and L. infan-
tum as single agents was found among CVBD-suspect
dogs (Table 5). In addition, the four combinations of
mixed agents with significantly higher seroreactivity in
the suspect group included E. canis, L. infantum and D.
immitis (Table 5). Furthermore, positivity to these
agents, either as single or mixed pathogens, were
identified as risk factors for clinical signs compatible
with CVBDs. These observations firmly suggest that
leishmaniosis, ehrlichiosis and dirofilariosis should be
considered by practitioners in their diagnostic routine.
The fact that some CVBD-suspect dogs were negative to
the agents assessed raises the hypothesis that they were
infected with other vector-borne pathogens, e.g. Babesia
canis, Rickettsia conorii or Hepatozoon canis [25,31].
Many dogs infected with vector-borne agents remain
asymptomatic for months or even years, but diagnosis
of subclinical infection is important, as those animals
might still serve as reservoirs of pathogens to other
hosts including humans [2]. In areas of endemicity, an
annual serological screening would be recommended to
promote early detection and treatment.
Conclusions
In conclusion, the present study provides evidence that
dogs in Portugal are at risk of becoming infected with
vector-borne pathogens, some of which are of zoonotic
concern. Although exposure can vary according to agent
and geographical region, the likelihood of infection with
at least one agent is considerable countrywide. In effect,
CVBDs caused by single or mixed agents should be
taken into account in the clinical management of canine
patients. Moreover, prophylactic measures, including the
use of ectoparasiticides against arthropods, must be put
in place in order to protect dogs and simultaneously
limit the risk of zoonotic transmission of vector-borne
pathogens. Finally, this study is expected to give veterin-
ary and public health authorities an increased awareness
about the picture of CVBDs in Portugal with a view to
establishing future control programs.
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